Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NuGen Medical Devices Inc V.NGMD

Alternate Symbol(s):  NGMDF

NuGen Medical Devices Inc. is a Canada-based specialty medical device company. The Company is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. It is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. It is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The Company's InsuJet technology platform is based on jet-stream administration of liquid drugs. The Company manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.


TSXV:NGMD - Post by User

NuGen Medical Devices Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by WallstreetTigeron Oct 24, 2023 10:47pm
210 Views
Post# 35699396

11.10.2023

11.10.2023
 https://www.investorx.ca/doc/2310110637435390


page 9 : The distribution agreement with Sol-M on July 25, 2023 to include
France, Spain and Portugal, and presently Italy and Switzerland are
being negotiated. The first order for Spain was received in Q3 2023. The
first large bulk sales in key markets such as Canada are postponed until
Q1 2024, as Sol-M will market the needle-free system under their own
brand, co-branded with InsuJet.
 : 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities